lactose has been researched along with diclofenac in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (25.00) | 18.2507 |
| 2000's | 5 (25.00) | 29.6817 |
| 2010's | 8 (40.00) | 24.3611 |
| 2020's | 2 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, SC; Kao, YH; Liu, CH; Sheu, MT; Sokoloski, TD | 1 |
| Bowtell, R; Davies, MC; Mansfield, P; Melia, CD; Peters, A; Rajabi-Siahboomi, AR; Sharp, JC | 1 |
| Fang, CL; Fang, JY; Lin, HH; Sung, KC | 1 |
| Ford, JL; McCrystal, CB; Rajabi-Siahboomi, AR | 2 |
| Ford, JL; Rajabi-Siahboomi, AR; Rubinstein, MH; Sadeghi, F | 2 |
| Bettini, R; Catellani, PL; Colombo, P; Massimo, G; Peppas, NA; Santi, P | 1 |
| Gong, W; Li, B; Zheng, C; Zhu, J | 1 |
| Dvorácková, K; Krejcová, K; Masteiková, R; Muselík, J; Rabisková, M | 1 |
| Awari, JG; Kilor, VA; Sapkal, NP; Shewale, BD | 1 |
| Dey, S; Gupta, SD; Khila, S; Mahanti, B; Mazumder, B | 1 |
| Badr, RM; Emara, LH; Mursi, NM; Taha, NF | 1 |
| Aguilar-de-Leyva, A; Caraballo, I; Cifuentes, C; Rajabi-Siahboomi, AR | 1 |
| Epstein, OI; Gavrilova, ES; Knopp, D; Niessner, R; Pschenitza, M; Tarasov, SА | 1 |
| Ivone, R; Lin, X; Shen, J; Wang, X; Xie, L; Yang, G; Yang, Y | 1 |
| Gharaibeh, SF; Lahlouh, IK; Obeidat, WM | 1 |
1 trial(s) available for lactose and diclofenac
| Article | Year |
|---|---|
In-vitro and in-vivo studies of the diclofenac sodium controlled-release matrix tablets.
Topics: Adult; Chromatography, High Pressure Liquid; Cross-Over Studies; Delayed-Action Preparations; Diclofenac; Hardness; Humans; Lactose; Male; Methylcellulose; Oxazines; Solubility; Tablets | 1995 |
19 other study(ies) available for lactose and diclofenac
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
NMR microscopy of hydrating hydrophilic matrix pharmaceutical tablets.
Topics: Diclofenac; Gels; Lactose; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Methylcellulose; Oxazines; Tablets | 1994 |
Transdermal iontophoretic delivery of diclofenac sodium from various polymer formulations: in vitro and in vivo studies.
Topics: Administration, Cutaneous; Anesthesia; Animals; Cellulose; Chemistry, Pharmaceutical; Diclofenac; Drug Interactions; Humans; In Vitro Techniques; Iontophoresis; Lactose; Male; Methylcellulose; Microdialysis; Oxazines; Polymers; Povidone; Rats; Rats, Wistar; Zingiberales | 1999 |
Water distribution studies within cellulose ethers using differential scanning calorimetry. 1. Effect of polymer molecular weight and drug addition.
Topics: Calorimetry, Differential Scanning; Cellulose; Diclofenac; Differential Thermal Analysis; Ethers; Gels; Lactose; Methylcellulose; Molecular Weight; Oxazines; Pharmaceutical Preparations; Propranolol; Thermodynamics; Water | 1999 |
Water distribution studies within cellulose ethers using differential scanning calorimetry. 2. Effect of polymer substitution type and drug addition.
Topics: Calorimetry, Differential Scanning; Cellulose; Diclofenac; Differential Thermal Analysis; Ethers; Gels; Lactose; Methylcellulose; Molecular Weight; Oxazines; Pharmaceutical Preparations; Propranolol; Thermodynamics; Water | 1999 |
Comparative study of drug release from pellets coated with HPMC or Surelease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cellulose; Chemistry, Pharmaceutical; Delayed-Action Preparations; Diclofenac; Drug Compounding; Lactose; Methylcellulose; Oxazines; Solubility; Water | 2000 |
Translocation of drug particles in HPMC matrix gel layer: effect of drug solubility and influence on release rate.
Topics: Diclofenac; Drug Delivery Systems; Gels; Lactose; Methylcellulose; Nitrofurantoin; Oxazines; Pyrrolidines; Solubility | 2001 |
Study of drug release from pellets coated with Surelease containing hydroxypropylmethylcellulose.
Topics: Algorithms; Anti-Inflammatory Agents, Non-Steroidal; Cellulose; Delayed-Action Preparations; Diclofenac; Dopamine Antagonists; Drug Delivery Systems; Drug Design; Lactose; Methylcellulose; Metoclopramide; Oxazines; Permeability; Sclerosing Solutions | 2001 |
A novel system for three-pulse drug release based on "tablets in capsule" device.
Topics: Alginates; Capsules; Chemistry, Pharmaceutical; Delayed-Action Preparations; Diclofenac; Drug Carriers; Drug Compounding; Excipients; Glucuronic Acid; Hardness; Hexuronic Acids; Hypromellose Derivatives; Kinetics; Lactose; Methylcellulose; Sodium Chloride; Solubility; Tablets; Technology, Pharmaceutical | 2008 |
Soluble filler as a dissolution profile modulator for slightly soluble drugs in matrix tablets.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Delayed-Action Preparations; Diclofenac; Drug Carriers; Excipients; Fatty Alcohols; Lactose; Particle Size; Povidone; Solubility; Sucrose; Tablets; Time Factors | 2009 |
Development and characterization of enteric-coated immediate-release pellets of aceclofenac by extrusion/spheronization technique using kappa-carrageenan as a pelletizing agent.
Topics: Acrylic Resins; Anti-Inflammatory Agents, Non-Steroidal; beta-Cyclodextrins; Biological Availability; Carrageenan; Chemistry, Pharmaceutical; Diclofenac; Drug Implants; Excipients; Lactose; Particle Size; Pharmaceutical Preparations; Polymers; Povidone; Solubility | 2010 |
Formulation development and optimization of bilayer tablets of aceclofenac.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cellulose; Chemistry, Pharmaceutical; Delayed-Action Preparations; Diclofenac; Drug Delivery Systems; Lactose; Methylcellulose; Solubility; Tablets | 2012 |
Development of an osmotic pump system for controlled delivery of diclofenac sodium.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cellulose; Chemistry, Pharmaceutical; Delayed-Action Preparations; Diclofenac; Excipients; Hydrophobic and Hydrophilic Interactions; Hypromellose Derivatives; Kinetics; Lactose; Membranes, Artificial; Methylcellulose; Microscopy, Electron, Scanning; Osmosis; Plasticizers; Polyethylene Glycols; Porosity; Potassium Chloride; Sodium Chloride; Solubility; Surface Properties; Tablets; Technology, Pharmaceutical; Triacetin | 2012 |
Critical points in ethylcellulose matrices: influence of the polymer, drug and filler properties.
Topics: Carbamazepine; Cellulose; Chemistry, Pharmaceutical; Diclofenac; Drug Compounding; Kinetics; Lactose; Particle Size; Polymers; Porosity; Pressure; Solubility; Tablets; Verapamil; Viscosity | 2013 |
Application of a heterogeneous immunoassay for the quality control testing of release-active forms of diclofenac.
Topics: Antibodies; Diclofenac; Drug Liberation; Enzyme-Linked Immunosorbent Assay; Humans; Lactose; Protein Binding; Quality Control; Reference Standards; Water | 2014 |
A tunable extruded 3D printing platform using thermo-sensitive pastes.
Topics: Cellulose; Delayed-Action Preparations; Diclofenac; Excipients; Gelatin; Glycerol; Hydrodynamics; Hypromellose Derivatives; Ibuprofen; Lactose; Mannitol; Printing, Three-Dimensional; Rheology; Technology, Pharmaceutical; Viscosity; Water | 2020 |
Investigations on Compaction Behavior of Kollidon
Topics: Delayed-Action Preparations; Diclofenac; DNA; Lactose; Povidone; Tablets | 2023 |